Design, synthesis, and biological studies of isoniazid-based hydrazone Derivatives: Antibacterial, anticancer, and enzyme inhibitory properties
Archives of Biochemistry and Biophysics · 2025
DOI: 10.1016/j.abb.2025.110450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Erbay Kalay und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, 36100, Kars, Türkiye. Hauptthemen laut MEDLINE: Hydrazones, Isoniazid, Anti-Bacterial Agents, Antineoplastic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Discovery of novel and effective molecules is of vital importance in solving global health problems such as cancer, neurodegenerative diseases and antibiotic resistance. In this study, a series of isoniazid-based hydrazone derivatives were synthesized for the first time via the condensation of isoniazid with structurally diverse aldehydes, including Mannich base, acylated, and sulfonate-containing derivatives. The primary focus was to assess their anticancer properties, antibacterial efficacy, and enzyme inhibition potential, contributing to the development of promising therapeutic agents. In addition, enzyme inhibition mechanisms were predicted by molecular docking methods, structural explanations were made for the biological activities and drug likeness characters of these molecules. The highest inhibitory effects were exhibited by compounds 6a for hCAI, 5b for hCAII, and 6a for AChE with Ki constants of 0.020 ± 0.003, 0.019 ± 0.002, and 0.027 ± 0.004 μM respectively. For hCAs acetazoleamide was used as standard inhibitor (having IC50 0.068 μM and 0.273 μM for hCAI and hCAII) and tacrine was used for AChE with 0.047 μM IC50. Compound 5b showed the highest binding scores for all enzymes in molecular docking tests having -8.15, -8.56, and -11.09 kcal/mol against CAI, CAII and AChE receptors. For both antibacterial and anticancer research, compound 5b had the most significant outcomes. In particular, mechanistic investigation of antibacterial, anticancer and enzyme inhibition effects will help new treatment options and better understanding of biochemical mechanisms. The study presents a new and up-to-date technique for chemical synthesis and biological evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, 36100, Kars, Türkiye.
- Muş Alparslan University, Faculty of Applied Sciences, Department of Plant Production and Technologies, 49250, Mus, Türkiye.
- St. James's University Hospital, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
- Eastern Anatolia High Technology Application and Research Center, Atatürk University, 25240, Erzurum, Türkiye.
- Department of Chemistry, Faculty of Science, Atatürk University, 25240, Erzurum, Türkiye.
- Department of Basic Science, Faculty of Science, Erzurum Technical University, 25050, Erzurum, Türkiye. Electronic address: ramazan.kalin@erzurum.edu.tr.
Zitieren
APA
Kalay, E., Korkmaz, I. N., Kacı, F. N., Aslan, O. N., Güller, P., Tokalı, F. S., & Kalın, R. (2025). Design, synthesis, and biological studies of isoniazid-based hydrazone Derivatives: Antibacterial, anticancer, and enzyme inhibitory properties. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110450
Vancouver
Kalay E, Korkmaz IN, Kacı FN, Aslan ON, Güller P, Tokalı FS, et al. Design, synthesis, and biological studies of isoniazid-based hydrazone Derivatives: Antibacterial, anticancer, and enzyme inhibitory properties. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110450
BibTeX
@article{Kalay2025,
author = {Kalay, Erbay and Korkmaz, Işıl Nihan and Kacı, Fatma Necmiye and Aslan, Osman Nuri and Güller, Pınar and Tokalı, Feyzi Sinan and Kalın, Ramazan},
title = {Design, synthesis, and biological studies of isoniazid-based hydrazone Derivatives: Antibacterial, anticancer, and enzyme inhibitory properties},
journal = {Archives of Biochemistry and Biophysics},
year = {2025},
doi = {10.1016/j.abb.2025.110450}
}
EUVIMED